TriSalus Life Sciences

United States
Calexico, California, United States, 80031

Company profile

TriSalus Life Sciences company profile

TriSalus Life Sciences, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The company's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, which collapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.

Business identity

Contact email
[email protected]
Phone number
+1 3034261223
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$1M-$10M
Founded
2009-01-01, Year

Headquarters

Postal code
80031
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
7
Total equity funding
$97.6M
Last funding
Post IPO Equity / $22M / 2025-05-08
Last equity funding
Post IPO Equity / $22M
Investors
7
Lead investors
5
Founders
2
Articles
115
Exited on
2023-08-10

Founders and investors

Founders

Aravind ArepallyJames E. Chomas

Lead investors

High Country VentureOrbiMedORI CapitalPartisan Management GroupTullis Health Investors

Investors

High Country VentureOrbiMedORI CapitalPartisan Management GroupTullis Health Investors